← Back to catalogue

StrepPRO™

FDA UDI

Class I (US FDA UDI)

by Hardy Diagnostics

Identity

Trade Name
StrepPRO™ FDA UDI
Generic Name
Beta-haemolytic Streptococcus serological grouping IVD, reagent FDA UDI
Device Name
StrepPRO™ Positive Control, for the rapid latex agglutination test, 60 tests Positive Control for the rapid latex agglutination test for the identification of streptococcal groups. FDA UDI
Model / Reference
PL040HD FDA UDI
Description
StrepPRO™ Positive Control, for the rapid latex agglutination test, 60 tests Positive Control for the rapid latex agglutination test for the identification of streptococcal groups. FDA UDI

Identifiers

Catalog Number
PL040HD FDA UDI
Primary DI / UDI-DI
00819398027946 FDA UDI
FDA Product Code
GTZ FDA UDI
GMDN Term
Beta-haemolytic Streptococcus serological grouping IVD, reagent FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
866.3740 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Beta-haemolytic Streptococcus serological grouping IVD, reagent

StrepPRO™ by Hardy Diagnostics — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Beta-haemolytic Streptococcus serological grouping IVD, reagent.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Hardy Diagnostics

Sources (1)

  • FDA UDI fb71f710-8c55-4d1e-b29d-00a03702dce7 36 fields · synced May 30, 2026